An Effectiveness And Safety Study Of PD 0299685 For The Treatment Of Symptoms Associated With Interstitial Cystitis

• Status: Completed
• Trial end date: 2010-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine whether PD 0299685 is effective in the treatment of symptoms associated with interstitial cystitis/painful bladder syndrome, such as pain, urinary urgency and frequency. At the same time assess the drug's safety and tolerability.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer

Criteria

Inclusion Criteria:

• Men and women over 18 years of age with moderate to severe interstitial cystitis defined by pain score.

• Women must not be pregnant or lactating, They may be post-menopausal, surgically sterilized or using an appropriate method of contraception.

Exclusion Criteria:

• History of interstitial cystitis less than 6 months

• History of current or recurrent urinary tract infections, or genitourinary cancer

• Any previous urinary diversion procedure with or without bladder removal, bladder augmentation

• Use of certain drugs given into the bladder up to 1 month prior to study entry